Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Asia supercharges vaccination efforts after slow start, U.S. lags

Published 09/16/2021, 05:47 AM
Updated 09/16/2021, 05:52 AM
© Reuters. FILE PHOTO: A health official draws a dose of the AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo, Sri Lanka January 29, 2021. REUTERS/Dinuka Liyanawatte/File Photo

By Rocky Swift and Aradhana Aravindan

TOKYO/SINGAPORE (Reuters) - Several Asian nations are quickly ramping up vaccination campaigns from shaky starts to combat growing COVID-19 infections, as supply shipments roll in and people overcome hesitancy in hopes of easing curbs and freeing up travel.

Japan and South Korea have passed the United States in terms of those who have received at least one dose and are fast catching up with the second.

And Australia, which is targeting high vaccination rates in its drive to escape lockdowns and re-open borders, has given 56% of people at least one shot as infections peak.

"That 70% double dose and 80% double dose mark is within plain sight," Prime Minister Scott Morrison told media on Thursday in the capital, Canberra. "Keep going, Australia."

While each country's inoculation strategies differ, Asia's momentum reflects pent-up demand for the shots as a means to ease lockdowns, said Paul Griffin, an infectious disease expert at the University of Queensland in northeast Australia.

Australia is giving priority supplies to its largest cities, which are in lockdown to contain a third wave of infections fuelled by the Delta variant. It expects to have enough to complete vaccinations of those older than 12 by mid-October.

Japan has overcome initial logistics hurdles to give https://www.reuters.com/world/asia-pacific/japan-city-uses-tsunami-lessons-covid-19-vaccinations-2021-06-11 about a million shots a day since mid-June, as urgency has grown after Delta unleashed an unprecedented wave of infections and serious cases in August.

"That obviously accelerated the vaccination motivation, particularly in young and middle-age groups," said Takahiro Kinoshita, a physician and official of vaccine information group Cov-Navi.

Japan's vaccination rate reflected a push to "return to a normal way of life," Prime Minister Yoshihide Suga, who will step down this month after a one-year tenure marred by an unpopular COVID-19 response, said on Thursday.

Vaccine take-up was also boosted by consistent public messaging to counter health scares that have doomed similar previous drives, said Fumie Sakamoto, an infection control manager at St. Luke's International Hospital in Tokyo.

CARROT AND STICK

Still, experts agree that vaccinations will plateau everywhere.

For instance, the United States and Britain, which had raced ahead to vaccinate millions of people a couple of months ago, are now seeing stagnating inoculation rates as large swathes of their populations reject the shots.

To counter the slowdown and a groundswell of anti-vaccine sentiment, U.S. President Joe Biden announced https://www.reuters.com/legal/government/how-will-bidens-vaccine-mandate-impact-workers-companies-2021-09-13 new mandates this week.

"I think they don't have that same incentive that perhaps we do (in Australia), where we relied on very harsh restrictions to keep people safe ... and are being told our only ticket to freedom is to have high levels of vaccination," said Griffin.

China, where more than 70% of the population have received both doses, said this month that it was difficult to expand its vaccination drive but did not say where the roadblocks were.

In wealthy Singapore, the most inoculated nation in Asia with more than 80% people fully vaccinated, is turning its focus to booster doses as infections spike.

While there are some holdouts, especially among the elderly and those worried about side effects from the new mRNA vaccines, people have a high level of trust in the government, which helps with compliance.

"If the carrot is we're going to ease restrictions if we get the vaccination rate high enough, then that will sway some people, it still won't sway the completely recalcitrant," said infectious diseases expert Dale Fisher, of the city state's National University Hospital.

Singapore has tied its reopening to vaccination rate milestones and set limits on unvaccinated people dining at restaurants.

South Korea, which struggled to get vaccine supplies initially, has supercharged its campaign, thanks to increased shipments.

© Reuters. FILE PHOTO: A health official draws a dose of the AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo, Sri Lanka January 29, 2021. REUTERS/Dinuka Liyanawatte/File Photo

It is likely to reach more than 70% of its population with a first dose before this week, an official said on Thursday.

India, with the world's second-highest tally of infections, has given 42% of its population of nearly 1.4 billion at least one dose, after months of production shortages and high demand.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.